by Benzinga Insights | Oct 12, 2026 | General
On Thursday, Blend Labs (NYSE:BLND) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit...
by Vandana Singh | Oct 12, 2026 | General
First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX) on Monday released topline results from Cohort 1 of its Phase 1b clinical trial of ANB033 in celiac disease. Following the announcement, the stock jumped more than 13%. The clinical-stage biotechnology firm designed...
by Lekha Gupta | Oct 12, 2026 | General
Fastly, Inc. (NASDAQ:FSLY) stock is edging lower in Monday’s premarket trading after surging 15.86% on Friday, following a bullish analyst upgrade driven by improving growth prospects and artificial intelligence opportunities. Oppenheimer Sees Growth Potential On...
by Avi Kapoor | Oct 12, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst Daniel Moore upgraded Hub Group Inc (NASDAQ:HUBG)...
by Benzinga Insights | Oct 12, 2026 | General
Profound Medical (TSX:PRN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit...
Recent Comments